Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
21.32
Dollar change
-0.08
Percentage change
-0.37
%
IndexRUT P/E- EPS (ttm)-3.20 Insider Own4.69% Shs Outstand89.90M Perf Week-4.39%
Market Cap1.92B Forward P/E82.26 EPS next Y0.26 Insider Trans-1.37% Shs Float85.66M Perf Month-1.34%
Income-263.30M PEG- EPS next Q-0.10 Inst Own101.36% Short Float5.61% Perf Quarter7.79%
Sales753.20M P/S2.54 EPS this Y108.64% Inst Trans1.69% Short Ratio7.41 Perf Half Y31.04%
Book/sh8.71 P/B2.45 EPS next Y1010.73% ROA-20.54% Short Interest4.80M Perf Year-6.53%
Cash/sh1.58 P/C13.48 EPS next 5Y-8.20% ROE-31.55% 52W Range13.82 - 24.21 Perf YTD11.39%
Dividend Est.- P/FCF- EPS past 5Y- ROI-28.65% 52W High-11.94% Beta1.96
Dividend TTM- Quick Ratio1.87 Sales past 5Y4.63% Gross Margin62.96% 52W Low54.27% ATR (14)0.89
Dividend Ex-Date- Current Ratio2.01 EPS Y/Y TTM-131.34% Oper. Margin-19.33% RSI (14)43.74 Volatility2.85% 4.43%
Employees2700 Debt/Eq0.19 Sales Y/Y TTM11.03% Profit Margin-34.96% Recom2.85 Target Price23.75
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q30.17% Payout- Rel Volume0.90 Prev Close21.40
Sales Surprise0.92% EPS Surprise181.69% Sales Q/Q10.57% EarningsFeb 27 AMC Avg Volume647.76K Price21.32
SMA20-2.81% SMA50-3.33% SMA2009.29% Trades Volume581,239 Change-0.37%
Date Action Analyst Rating Change Price Target Change
Dec-21-23Resumed Piper Sandler Neutral $23
Dec-19-23Initiated Wells Fargo Equal Weight $20
Dec-14-23Initiated Guggenheim Buy $23
Dec-13-23Initiated Wolfe Research Outperform $28
Jul-05-23Resumed JP Morgan Underweight $18
May-23-23Upgrade Goldman Sell → Buy $18 → $25
Jan-18-23Upgrade Raymond James Mkt Perform → Outperform $25
Oct-06-22Initiated Stephens Equal-Weight $22
Oct-15-21Resumed Cowen Market Perform $33
Jun-15-21Initiated Raymond James Mkt Perform
Today 11:30AM
Mar-27-24 07:51AM
Mar-21-24 09:40PM
Mar-20-24 04:05PM
Mar-01-24 09:41AM
02:45PM Loading…
Feb-28-24 02:45PM
11:24AM
10:24AM
07:50AM
Feb-27-24 07:00PM
06:30PM
04:42PM
04:05PM
09:15AM
Feb-26-24 09:16AM
04:05PM Loading…
Feb-21-24 04:05PM
Feb-16-24 07:05AM
Feb-15-24 04:05PM
Feb-01-24 09:25AM
Jan-30-24 05:00PM
Jan-25-24 07:05PM
Jan-22-24 08:55AM
Jan-18-24 06:10PM
Jan-09-24 04:05PM
Jan-04-24 11:10AM
Jan-03-24 04:05PM
Dec-21-23 03:05PM
09:17AM
08:30AM
Dec-20-23 08:00AM
08:22AM Loading…
Dec-14-23 08:22AM
Dec-06-23 11:30AM
Nov-21-23 10:54AM
Nov-20-23 04:05PM
11:18AM
Nov-16-23 04:05PM
Nov-09-23 07:00AM
Nov-08-23 09:20PM
04:10PM
Nov-07-23 02:30PM
10:24AM
10:09AM
Nov-06-23 07:00PM
04:59PM
04:36PM
04:05PM
Nov-04-23 03:02AM
Nov-03-23 07:04PM
Nov-01-23 09:00AM
Oct-31-23 04:05PM
Oct-30-23 03:46PM
Oct-26-23 08:00AM
Oct-20-23 10:31AM
Oct-09-23 06:56PM
Sep-29-23 11:44AM
Sep-28-23 04:59PM
07:00AM
Sep-22-23 11:51AM
Sep-20-23 07:42AM
Sep-19-23 09:00AM
07:00AM
Sep-18-23 08:00AM
Sep-12-23 11:41AM
Sep-08-23 11:49AM
Sep-07-23 11:30AM
Sep-06-23 04:05PM
07:00AM
Sep-05-23 08:00AM
Aug-23-23 09:48AM
Aug-22-23 09:00AM
Aug-17-23 04:05PM
Aug-16-23 08:36AM
Aug-15-23 07:05AM
Aug-11-23 10:34AM
Aug-08-23 04:05PM
Aug-07-23 04:05PM
12:12PM
Aug-05-23 08:29AM
Aug-04-23 09:00PM
07:08PM
07:09AM
Aug-03-23 06:35PM
04:05PM
Jul-27-23 04:05PM
Jul-24-23 08:00AM
Jul-06-23 08:30AM
Jun-30-23 11:16AM
Jun-28-23 09:32AM
Jun-21-23 08:00PM
Jun-17-23 07:00AM
Jun-13-23 08:16AM
Jun-12-23 08:00AM
Jun-07-23 04:05PM
Jun-01-23 08:00AM
07:36AM
May-31-23 08:00AM
May-25-23 12:25PM
May-24-23 04:05PM
May-23-23 06:56PM
01:25PM
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riggsbee Richard BryanChief Financial OfficerDec 01 '23Sale19.0930,000572,835291,812Dec 05 04:19 PM
Riggsbee Richard BryanChief Financial OfficerNov 01 '23Sale15.6930,000470,622321,812Nov 03 05:12 PM
SPIEGELMAN DANIEL KDirectorJun 02 '23Sale23.018,638198,76040,493Jun 02 06:15 PM